Your browser doesn't support javascript.
loading
Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer.
Adams, S; Diéras, V; Barrios, C H; Winer, E P; Schneeweiss, A; Iwata, H; Loi, S; Patel, S; Henschel, V; Chui, S Y; Rugo, H S; Emens, L A; Schmid, P.
Affiliation
  • Adams S; Department of Medicine, Perlmutter Breast Cancer Center, New York University Langone Medical Center, New York, USA. Electronic address: Sylvia.Adams@nyulangone.org.
  • Diéras V; Department of Medical Oncology, Institut Curie, Paris and Centre Eugène Marquis, Rennes, France.
  • Barrios CH; Department of Oncology, Centro de Pesquisa Clinica HSL, PUCRS, Porto Alegre, Brazil.
  • Winer EP; Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
  • Schneeweiss A; Division of Gynecologic Oncology, University Hospital and German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Loi S; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Patel S; Genentech, Inc., South San Francisco, USA.
  • Henschel V; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Chui SY; Genentech, Inc., South San Francisco, USA.
  • Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.
  • Emens LA; Division of Hematology/Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, USA.
  • Schmid P; Department of Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.
Ann Oncol ; 31(5): 582-589, 2020 05.
Article in En | MEDLINE | ID: mdl-32178964
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Triple Negative Breast Neoplasms / Patient Reported Outcome Measures Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Triple Negative Breast Neoplasms / Patient Reported Outcome Measures Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United kingdom